Retrospective Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Apr 28, 2015; 21(16): 4933-4945
Published online Apr 28, 2015. doi: 10.3748/wjg.v21.i16.4933
Table 4 Characteristics of hepatocellular carcinoma patients with hepatitis C virus infection
VariablesAll patients (n = 100)LL group (n = 34)HL group (n = 39)HH group (n = 27)P value
Age (yr)71 (62-77)72 (64-77)70 (62-75)70 (65-77)0.766
Sex, male/female82/1822/1229/1016/110.413
Body mass index23.6 ± 3.623.6 ± 2.923.8 ± 3.823.4 ± 4.10.737
Open/Pure Lap/Lap-assisted77/12/1126/3/527/8/424/1/20.218
Hr
0/S/1/2/357/27/11/2/323/8/3/0/021/10/5/1/213/9/3/1/10.784
Preoperative laboratory values
Aspartate transaminase (U/L)47 (30-64)41 (23-56)48 (35-67)53 (47-71)0.101
Alanine transaminase (U/L)38 (26-57)33 (21-53)41 (28-57)42 (29-62)0.496
Platelets (× 104/μL)13.5 ± 6.813.9 ± 4.713.9 ± 9.212.5 ± 4.40.804
Serum ALB (g/dL)3.76 ± 0.393.94 ± 0.403.67 ± 0.353.67 ± 0.380.0061
PT (%)89.8 ± 13.492.5 ± 11.487.8 ± 15.089.2 ± 13.50.254
Serum TBIL (mg/dL)0.78 ± 0.340.74 ± 0.320.79 ± 0.330.81 ± 0.390.777
ICGR1514.2 (8.4-18.5)12.1 (8.1-15.4)14.7 (8.4-21.5)15.6 (13.0-24.6)0.163
AFP (ng/mL)18.6 (5.6-134.0)5.3 (3.8-11.0)21.1 (6.9-99.2)299.7 (68.1-1046.0)< 0.0011
DCP (mAU/mL)45 (21-244)22 (15-35)37 (23-134)429 (124-1902)< 0.0011
Intraoperative data
Blood loss (mL)330 (20-650)263 (70-500)230 (20-500)535 (300-1270)0.0061
Surgical duration (min)304 (230-377)303 (175-377)296 (230-352)345 (282-475)0.0401
Blood transfusion
RCC: yes/no (%)12/88 (12.0%)3/31 (8.8%)2/37 (5.1%)7/20 (25.9%)0.0301
Pathologic results
Tumor size (cm)3.51 ± 2.482.84 ± 1.233.26 ± 2.314.72 ± 3.390.0081
Multiple tumor: yes/no (%)36/64 (36.0%)8/26 (23.5%)17/22 (43.6%)11/16 (40.7%)0.171
Vascular invasion: yes/no (%)30/70 (30.0%)5/29 (14.7%)12/27 (30.8%)13/14 (48.1%)0.0181
Remnant liver: NL/CH/LC5/37/582/18/142027/10/22017/9/10.161
Histological tumor differentiation
Well/Moderately/Poorly17/63/207/23/48/24/72/16/90.213
Recurrence within 2 yr after hepatectomy
Yes/no (%)51/49 (51.0%)